Akero Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 7.90 M | $226.55 M | 54.39% | 11.37% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 7.08 M | $203.05 M | 2.93% | 10.19% |
| RTW INVESTMENTS, LP | 11/14/2024 | 5.92 M | $169.83 M | 8.97% | 8.52% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 5.75 M | $164.90 M | 100.00% | 8.28% |
| GENERAL ATLANTIC, L.P. | 11/12/2024 | 5.23 M | $150.16 M | 0.00% | 7.54% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 3.81 M | $109.26 M | -8.15% | 5.48% |
| VANGUARD GROUP INC | 11/13/2024 | 3.68 M | $105.48 M | -0.77% | 5.29% |
| ALKEON CAPITAL MANAGEMENT LLC | 11/14/2024 | 3.33 M | $95.39 M | -0.07% | 4.79% |
| STATE STREET CORP | 11/14/2024 | 2.50 M | $71.81 M | -6.93% | 3.60% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 2.02 M | $57.87 M | 5.73% | 2.90% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 1.71 M | $49.20 M | 14.33% | 2.47% |
| BOXER CAPITAL, LLC | 11/14/2024 | 1.68 M | $48.11 M | 0.00% | 2.41% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.57 M | $45.08 M | -2.97% | 2.26% |
| REDMILE GROUP, LLC | 11/14/2024 | 1.39 M | $39.81 M | -14.06% | 2.00% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 1.30 M | $37.39 M | 100.00% | 1.88% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 1.30 M | $37.30 M | -26.43% | 1.87% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 1.10 M | $31.48 M | 0.00% | 1.58% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 933,399 | $26.78 M | -13.11% | 1.34% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 800,000 | $22.95 M | 0.00% | 1.15% |
| YIHENG CAPITAL MANAGEMENT, L.P. | 11/12/2024 | 758,769 | $21.77 M | -47.09% | 1.09% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 11/13/2024 | 719,604 | $20.65 M | 0.00% | 1.04% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 689,784 | $19.79 M | 100.00% | 0.99% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 662,321 | $19.00 M | -15.41% | 0.95% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 639,840 | $18.36 M | 2.36% | 0.92% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 532,596 | $15.28 M | -4.01% | 0.77% |
| EMERALD ADVISERS, LLC | 10/29/2024 | 524,427 | $15.05 M | 1.78% | 0.76% |
| JPMORGAN CHASE & CO | 12/26/2024 | 488,046 | $14.00 M | -10.00% | 0.70% |
| MORGAN STANLEY | 11/14/2024 | 448,070 | $12.86 M | -52.66% | 0.65% |
| UNIVERSITY OF WISCONSIN FOUNDATION | 11/14/2024 | 423,849 | $12.16 M | 0.00% | 0.61% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 10/29/2024 | 415,201 | $11.91 M | -2.28% | 0.60% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 392,544 | $11.26 M | 1.70% | 0.57% |
| PROPEL BIO MANAGEMENT, LLC | 11/13/2024 | 343,729 | $9.86 M | 4.87% | 0.50% |
| WOODLINE PARTNERS LP | 11/14/2024 | 292,468 | $8.39 M | 45.92% | 0.42% |
| SIMPLIFY ASSET MANAGEMENT INC. | 11/12/2024 | 283,766 | $8.14 M | 15.59% | 0.41% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 278,323 | $7.99 M | -37.00% | 0.40% |
| RHEOS CAPITAL WORKS INC. | 10/16/2024 | 276,000 | $7.92 M | 27.78% | 0.40% |
| FRED ALGER MANAGEMENT, LLC | 11/14/2024 | 269,601 | $7.73 M | 117.79% | 0.39% |
| JANE STREET GROUP, LLC | 11/15/2024 | 217,564 | $6.24 M | -15.52% | 0.31% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 206,844 | $5.93 M | -17.67% | 0.30% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 198,900 | $5.71 M | 100.00% | 0.29% |
| JANE STREET GROUP, LLC | 11/15/2024 | 191,300 | $5.49 M | 100.00% | 0.28% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2024 | 184,432 | $5.21 M | -25.17% | 0.27% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 174,903 | $5.02 M | 0.00% | 0.25% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 159,558 | $4.58 M | -39.15% | 0.23% |
| ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 155,044 | $4.45 M | -34.72% | 0.22% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 155,000 | $4.45 M | 100.00% | 0.22% |
| CITADEL ADVISORS LLC | 11/14/2024 | 149,901 | $4.30 M | -62.06% | 0.22% |
| PDT PARTNERS, LLC | 11/14/2024 | 139,296 | $4.00 M | 0.00% | 0.20% |
| BARCLAYS PLC | 11/19/2024 | 127,668 | $3.66 M | 127.91% | 0.18% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 124,500 | $3.57 M | 8.45% | 0.18% |
Akero Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 193 institutional investors and hedge funds held shares of Akero Therapeutics, Inc.. The most heavily invested institutionals were:
WELLINGTON MANAGEMENT GROUP LLP: 7.9 M
JANUS HENDERSON GROUP PLC: 7.08 M
RTW INVESTMENTS, LP: 5.92 M
BlackRock Funding, Inc. /DE: 5.75 M
GENERAL ATLANTIC, L.P.: 5.23 M
PRICE T ROWE ASSOCIATES INC /MD/: 3.81 M
105.12% of Akero Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 84.89 M shares in the last 24 months. This purchase volume represents approximately $1.86 B in transactions.